BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rahmati M, Keshvari M, Mirnasuri S, Yon DK, Lee SW, Il Shin J, Smith L. The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis. J Med Virol 2022;94:5112-27. [PMID: 35831242 DOI: 10.1002/jmv.27996] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Miura J, Uchigata Y. Update information on type 1 diabetes in children/adolescents and adults. J Diabetes Investig 2023;14:531-4. [PMID: 36659815 DOI: 10.1111/jdi.13961] [Reference Citation Analysis]
2 Knip M, Parviainen A, Turtinen M, But A, Härkönen T, Hepojoki J, Sironen T, Iheozor-Ejiofor R, Uğurlu H, Saksela K, Lempainen J, Ilonen J, Vapalahti O; Finnish Pediatric Diabetes Register. SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study. Lancet Diabetes Endocrinol 2023;11:251-60. [PMID: 36958868 DOI: 10.1016/S2213-8587(23)00041-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rebhun J, Shin CM, Siddiqui UD, Villa E. Endoscopic biliary treatment of unresectable cholangiocarcinoma: A meta-analysis of survival outcomes and systematic review. World J Gastrointest Endosc 2023; 15(3): 177-190 [DOI: 10.4253/wjge.v15.i3.177] [Reference Citation Analysis]
4 Zucchini S, Scozzarella A, Maltoni G. Multiple influences of the COVID-19 pandemic on children with diabetes: Changes in epidemiology, metabolic control and medical care. World J Diabetes 2023; 14(3): 198-208 [DOI: 10.4239/wjd.v14.i3.198] [Reference Citation Analysis]
5 Bombaci B, Passanisi S, Sorrenti L, Salzano G, Lombardo F. Examining the associations between COVID-19 infection and pediatric type 1 diabetes. Expert Rev Clin Immunol 2023;:1-9. [PMID: 36888906 DOI: 10.1080/1744666X.2023.2189587] [Reference Citation Analysis]
6 Steenblock C, Toepfner N, Beuschlein F, Perakakis N, Mohan Anjana R, Mohan V, Mahapatra NR, Bornstein SR. SARS-CoV-2 infection and its effects on the endocrine system. Best Pract Res Clin Endocrinol Metab 2023;:101761. [PMID: 36907787 DOI: 10.1016/j.beem.2023.101761] [Reference Citation Analysis]
7 Anindya R, Rutter GA, Meur G. New-onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection. Immunol Cell Biol 2023;101:191-203. [PMID: 36529987 DOI: 10.1111/imcb.12615] [Reference Citation Analysis]
8 Baechle C, Eckert A, Kamrath C, Neu A, Manuwald U, Thiele-Schmitz S, Weidler O, Knauer-Fischer S, Rosenbauer J, Holl RW. Incidence and presentation of new-onset type 1 diabetes in children and adolescents from Germany during the COVID-19 pandemic 2020 and 2021: Current data from the DPV Registry. Diabetes Res Clin Pract 2023;197:110559. [PMID: 36758641 DOI: 10.1016/j.diabres.2023.110559] [Reference Citation Analysis]
9 Faruqi J, Balasubramanyam A. COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic. Expert Rev Endocrinol Metab 2023;:1-13. [PMID: 36797835 DOI: 10.1080/17446651.2023.2176300] [Reference Citation Analysis]
10 Crocco M, Calvi A, Canzoneri F, Malerba F, Zampatti N, Chiaro A, Arrigo S, Gandullia P, Proietti S, Bonassi S. The Influence of SARS-CoV-2 Pandemic on the Diagnosis of Celiac Disease and Clinical Practice in Pediatric Gastroenterology. Nutrients 2023;15. [PMID: 36771266 DOI: 10.3390/nu15030559] [Reference Citation Analysis]
11 Meregildo-rodriguez ED, León-jiménez FE, Tafur-hoyos BAD, Vásquez-tirado GA. Impact of the COVID-19 pandemic on the incidence and clinical outcomes of diabetic ketoacidosis among male and female children with type 1 diabetes: systematic review and meta-analysis. F1000Res 2023;12:72. [DOI: 10.12688/f1000research.128687.1] [Reference Citation Analysis]
12 Lai PH, Ding DC. Acute liver injury in a COVID-19 infected woman with mild symptoms: A case report. World J Clin Cases 2023; 11(2): 472-478 [PMID: 36686361 DOI: 10.12998/wjcc.v11.i2.472] [Reference Citation Analysis]
13 Al-Mhanna SB, Wan Ghazali WS, Maqsood A, Mohamed M, Ahmed N, Afolabi HA, Mutalub YB, Heboyan A, Zafar MS. Physical activities pre- and post-COVID-19 vaccination and its implementations: A narrative review. SAGE Open Med 2023;11:20503121231158981. [PMID: 36909796 DOI: 10.1177/20503121231158981] [Reference Citation Analysis]
14 Rosenbauer J, Stahl-Pehe A, Schlesinger S, Kuß O. Comments on Rahmati et al., The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis. J Med Virol. 2022; 1-16 (doi: 10.1002/jmv.27996). J Med Virol 2023;95:e28272. [PMID: 36324006 DOI: 10.1002/jmv.28272] [Reference Citation Analysis]
15 Unnikrishnan A, Suganthi K, Lalvani N, Jevalikar G, Sarda A. A practical approach to the diagnosis of type 1 diabetes: An Indian perspective. Chron Diabetes Res Pract 2023;0:0. [DOI: 10.4103/cdrp.cdrp_19_22] [Reference Citation Analysis]
16 Berg SK, Palm P. Playing catch with long COVID - Understanding a new disease. Lancet Reg Health Eur 2023;25:100568. [PMID: 36597517 DOI: 10.1016/j.lanepe.2022.100568] [Reference Citation Analysis]
17 Zhang W, Ouyang DL, Che X. Short- and long-term outcomes of laparoscopic vs open surgery for T2 gallbladder cancer: A systematic review and meta-analysis. World J Gastrointest Surg 2022; 14(12): 1387-1396 [DOI: 10.4240/wjgs.v14.i12.1387] [Reference Citation Analysis]
18 Zhang T, Mei Q, Zhang Z, Walline JH, Liu Y, Zhu H, Zhang S. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med 2022;20:444. [PMID: 36380329 DOI: 10.1186/s12916-022-02656-y] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
19 Rahmati M, Keshvari M, Mirnasuri S, Yon DK, Lee SW, Il Shin J, Smith L. The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis. J Med Virol 2022;94:5112-27. [PMID: 35831242 DOI: 10.1002/jmv.27996] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
20 Raicevic M, Samardzic M, Soldatovic I, Curovic Popovic N, Vukovic R. Trends in nationwide incidence of pediatric type 1 diabetes in Montenegro during the last 30 years. Front Endocrinol 2022;13:991533. [DOI: 10.3389/fendo.2022.991533] [Reference Citation Analysis]
21 Sebastián-martín A, Sánchez BG, Mora-rodríguez JM, Bort A, Díaz-laviada I. Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology. Biomedicines 2022;10:2026. [DOI: 10.3390/biomedicines10082026] [Reference Citation Analysis]
22 Rajan R, Athale U, Ewusie JE, McAssey K, Thabane L, Samaan MC. An exploratory analysis of the impact of the COVID-19 pandemic on pediatric type 1 diabetes mellitus patient outcomes: A single-center study. Front Pediatr 2022;10:1038345. [PMID: 36467474 DOI: 10.3389/fped.2022.1038345] [Reference Citation Analysis]